Since then, a large number of studies have revealed a high incidence of thyroid abnormalities in IFN-α treated patients, ranging from development of thyroid autoantibodies to overt ATD such as GD or HD (30). The gene discussed is IFNA1; the disease is thyroid gland disorder.